SkincAIr Early detection and management of SKIN-related negleCted tropical diseases using Artificial Intelligence in sub-saharan afRica (SkincAIr)
- Coordinator
- Universidad Politecnica De Madrid, Spain
- Runs
- 1 June 2025 to 31 May 2030
- Status
- Running
- EU funding
- €4.9m
- Total cost
- €4.9m
- Partners
- 12 organisations in 10 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101190743
What the project is doing
In the project's own words, from its summary on CORDIS.
The SkincAIr project aims to develop an innovative AI-driven mobile application to support the early detection and of skin Neglected Tropical Diseases (skin NTDs) in Sub-Saharan Africa (SSA). NTDs significantly affect marginalized communities due to several factors, such as lack of trained healthcare staff and diagnostic tools. The project's objectives are: to improve the accuracy of Front-line Health Workers (FHW) of skin NTD identification, to create the largest public dataset of skin NTDs in the world (first in SSA), to reduce disease transmission through early diagnosis, to enhance real-time epidemiological surveillance, to enhance the knowledge of FHW, to develop novel AI models for skin disease monitoring, to ensure the digital solution is culturally tailored, to ensure compliance with clinical practices, ethical, legal aspects and participant rights, to ensure scalability and broad outreach of SkincAIr’s results, to advocate for greater awareness and policy support for NTDsSkincAIr will equip FHW with an app capable of detecting skin NTDs using advanced machine learning techniques while preserving privacy through geolocation features.
The app will facilitate real-time epidemiological surveillance, contributing to improved disease mapping and hotspot identification. The project will be implemented in five SSA countries: Kenya, Senegal, Ethiopia, Nigeria, and the Democratic Republic of the Congo. Aligned with the Work Program, SkincAIr is anchored in the scope of Global Health EDCTP3 and regional strategies, targeting the highest demonstrated medical needs in SSA and addressing context-specific needs.
It develops a solution with early-stage involvement of end users and implicated health services. The solution ensures seamless integration and interoperability, is sustainable, accessible, open-source, evidence-based, and compliant with data protection standards and global digital health public goods.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universidad Politecnica De Madrid | Madrid | Spain | Coordinator |
| Universite Catholique De Bukavu | Bukavu | CD | Participant |
| Fachhochschule Zentralschweiz - Hochschule Luzern | Luzern | Switzerland | Associatedpartner |
| Mtu Australo Alpha Lab | Tallinn | Estonia | Participant |
| Teacup Consulting SL | Madrid | Spain | Participant |
| Armauer Hansen Research Institute | Addis Ababa | ET | Participant |
| Oeuvres Hospitalieres Francaises De L'ordre De Malte | Paris | France | Participant |
| Kenya Medical Research Institute | Nairobi | Kenya | Participant |
| Omodi, Agasna, Odiembo Advocates Llp | Nairobi | Kenya | Participant |
| Leprosy and Tuberculosis Relief Initiative Nigeria | Jos | NG | Participant |
| Sherwood Healthcare Senegal SARL | Dakar | SN | Participant |
| King's College London | London | United Kingdom | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI